Minnesota SF 4083: Drug manufacturers reporting and maintaining of prescription drug prices requirement

Status: Referred to Health and Human Services Finance and Policy (as of 2020-03-05)

State: Minnesota · Session: 2019-2020 · Bill: SF 4083

Subjects: Commerce and Commerce Department, Drugs and Medicine, Health and Health Department, Insurance-Health

Sponsors: Jensen, Draheim, Klein, Rosen, Wiklund

View Minnesota SF 4083 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.